Glioblastoma (GBM) is one of the most aggressive and lethal human brain tumors. At
present, GBMs are divided in primary and secondary on the basis of the mutational status of …

Metformin is the first-line option for treating newly diagnosed diabetic patients and also
involved in other pharmacological actions, including antitumor effect, anti-aging effect …

Glioblastoma is the most common and most aggressive primary brain tumor. Despite
maximum treatment, patients only have a median survival time of 15 months, because of the …

The control of cell proliferation by microRNAs (miRNAs) is well established and the
alteration of these small, non-coding RNAs may contribute to tumor development by …

We explored the role of microRNAs (miRNAs) in acquiring resistance to tamoxifen, a drug
successfully used to treat women with estrogen receptor-positive breast cancer. miRNA …

Simple Summary Hepatocellular carcinoma (HCC) is one of the most frequently occurring
cancers, and the prognosis for late-stage HCC remains poor. A better understanding of the …

Key regulators of 3′ untranslated regions (3′ UTRs) are microRNAs and RNA-binding
proteins (RBPs),. The p27 tumour suppressor is highly expressed in quiescent cells, and its …

MicroRNAs (miRNAs) comprise a novel class of endogenous, small, noncoding RNAs that
negatively regulate gene expression. Functionally, an individual miRNA is as important as a …

Pancreatic cancer is the eighth most common cancer and has an overall 5‐year survival rate
lower than 10%. Because of their ability to regulate gene expression, microRNAs can act as …

MicroRNAs [1] have emerged as key post-transcriptional regulators of gene expression,
involved in various physiological and pathological processes. It was found that several …